A Multicenter Phase I/Ib Dose Escalation Study of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Patients with Selected Advanced or Metastatic Solid Tumors
| Protocol No. | CTO-WTX-124X2101 | Scope | National |
|---|---|---|---|
| Principal Investigator | Mateusz Opyrchal | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I |
